New drug brings hope for early Alzheimer's patients
CBS America · New
CBS America
New
There is progress to report in the battle against Alzheimer's. While there is still no cure, new tests and new treatments are presenting more options. Dr. Jon LaPook reports.
Breakdown
- Lekembe is a new drug approved for early-stage Alzheimer's patients. 1m 10s
- The drug works by removing amyloid plaques from the brain. 1m 18s
- Clinical studies show Lekembe can slow mental decline by about 30 percent over 18 months. 1m 35s
- Lekembe carries risks of brain swelling and bleeding, requiring regular MRI monitoring. 1m 44s
- The medication is costly but is expected to be covered by insurance in most cases. 2m 24s